BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 15938729)

  • 1. Nonmyeloablative peripheral blood stem cell transplant for T-cell prolymphocytic leukaemia complicated by fulminant haemolysis and acute renal failure at engraftment secondary to minor ABO incompatibility.
    Curtin NJ; Schwarer AP
    Clin Lab Haematol; 2005 Jun; 27(3):206-8. PubMed ID: 15938729
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Massive hemolysis following allogeneic peripheral blood stem cell transplantation with minor ABO incompatibility].
    Ishiyama M; Iwabe K; Hida M; Okamura T; Yoshinaga K; Hidai H; Kobayashi S; Sameshima Y; Mori N; Teramura M; Masuda M; Motoji T; Mizoguchi H
    Rinsho Ketsueki; 2002 Jun; 43(6):477-81. PubMed ID: 12134705
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early and fatal immune haemolysis after so-called 'minor' ABO-incompatible peripheral blood stem cell allotransplantation.
    Oziel-Taieb S; Faucher-Barbey C; Chabannon C; Ladaique P; Saux P; Gouin F; Gastaut JA; Maraninchi D; Blaise D
    Bone Marrow Transplant; 1997 Jun; 19(11):1155-6. PubMed ID: 9193761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prophylactic red blood cell exchange for prevention of severe immune hemolysis in minor ABO-mismatched allogeneic peripheral blood progenitor cell transplantation after reduced-intensity conditioning.
    Worel N; Greinix HT; Supper V; Leitner G; Mitterbauer M; Rabitsch W; Fischer G; Rosenmayr A; Höcker P; Kalhs P
    Transfusion; 2007 Aug; 47(8):1494-502. PubMed ID: 17655594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of T prolymphocytic leukemia with allogeneic bone marrow transplantation.
    Collins RH; Piñeiro LA; Agura ED; Fay JW
    Bone Marrow Transplant; 1998 Mar; 21(6):627-8. PubMed ID: 9580345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Massive immune haemolysis after allogeneic peripheral blood stem cell transplantation with minor ABO incompatibility.
    Bolan CD; Childs RW; Procter JL; Barrett AJ; Leitman SF
    Br J Haematol; 2001 Mar; 112(3):787-95. PubMed ID: 11260085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL
    Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pure red cell aplasia after allogeneic transplantation of ABO incompatible hematopoietic stem cells].
    Bullorsky E; Shanley C; Stemmelin G; Ceresetto J; Rabinovich O
    Medicina (B Aires); 2002; 62(6):575-7. PubMed ID: 12532694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune haemolysis after renal transplantation secondary to ABO minor-mismatch between donor and recipient.
    Jayaranee S; Ramesh P; Nadesan V
    Singapore Med J; 2002 Aug; 43(8):421-2. PubMed ID: 12507029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Major ABO-incompatible hematopoietic stem cell transplantation: study of post-transplant pure red cell aplasia and endothelial cell chimerism.
    Mueller RJ; Stussi G; Odermatt B; Halter J; Schanz U; Seebach JD
    Xenotransplantation; 2006 Mar; 13(2):126-32. PubMed ID: 16623806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinically significant anti-A(1) in a presumed ABO-identical hematopoietic stem cell transplant recipient: a case report.
    Jaben EA; Jacob EK; Tauscher C; D'Souza A; Hogan WJ; Stubbs JR
    Transfusion; 2013 Jan; 53(1):202-5. PubMed ID: 22574682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ABO-histo blood group incompatibility in hematopoietic stem cell and solid organ transplantation.
    Stussi G; Halter J; Schanz U; Seebach JD
    Transfus Apher Sci; 2006 Aug; 35(1):59-69. PubMed ID: 16935028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid donor type isoagglutinin production after allogeneic peripheral progenitor cell transplantation.
    Moog R; Melder C; Prumbaum M; Müller N; Schaefer UW
    Beitr Infusionsther Transfusionsmed; 1997; 34():150-2. PubMed ID: 9356666
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Minor ABO-mismatches are risk factors for acute graft-versus-host disease in hematopoietic stem cell transplant patients.
    Ludajic K; Balavarca Y; Bickeböller H; Rosenmayr A; Fischer GF; Faé I; Kalhs P; Pohlreich D; Kouba M; Dobrovolna M; Greinix HT
    Biol Blood Marrow Transplant; 2009 Nov; 15(11):1400-6. PubMed ID: 19822299
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ABO incompatible stem cell transplantation in children does not influence outcome.
    Helming AM; Brand A; Wolterbeek R; van Tol MJ; Egeler RM; Ball LM
    Pediatr Blood Cancer; 2007 Sep; 49(3):313-7. PubMed ID: 16960869
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of isohemagglutinin production following minor ABO incompatible unrelated HLA mismatched umbilical cord blood transplantation.
    Snell M; Chau C; Hendrix D; Fox R; Downes KA; Creger R; Meyerson H; Telen MJ; Laughlin MJ; Lazarus HM; Yomtovian R
    Bone Marrow Transplant; 2006 Jul; 38(2):135-40. PubMed ID: 16751785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Major ABO blood group mismatch increases the risk for graft failure after unrelated donor hematopoietic stem cell transplantation.
    Remberger M; Watz E; Ringdén O; Mattsson J; Shanwell A; Wikman A
    Biol Blood Marrow Transplant; 2007 Jun; 13(6):675-82. PubMed ID: 17531777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pure red-cell aplasia following major and bi-directional ABO-incompatible allogeneic stem-cell transplantation: recovery of donor-derived erythropoiesis after long-term treatment using different therapeutic strategies.
    Helbig G; Stella-Holowiecka B; Wojnar J; Krawczyk M; Krzemien S; Wojciechowska-Sadus M; Markiewicz M; Wylezol I; Kopera M; Holowiecki J
    Ann Hematol; 2007 Sep; 86(9):677-83. PubMed ID: 17486341
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [ABO incompatibility and non myeloablative allogeneic stem cell transplantation].
    Malfuson JV; Hicheri Y; Bonin P; Rodet M; Boccaccio C; Pautas C; Kuentz M; Cordonnier C; Noizat-Pirenne F; Maury S
    Transfus Clin Biol; 2007 Aug; 14(3):327-33. PubMed ID: 17462938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune hemolysis following ABO-mismatched stem cell or solid organ transplantation.
    Yazer MH; Triulzi DJ
    Curr Opin Hematol; 2007 Nov; 14(6):664-70. PubMed ID: 17898572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.